TSU-1621MT

Information for TSU-1621MT

Description

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
10
Transcriptional Factors
9
Peaks
388,533
Non-redundant peaks
161,426

Description

Cell_name
TSU-1621MT
Category
Cancer cell line
Disease
NCIt; C9154; Adult acute myeloid leukemia
Sex_gender_of_cell
Female
Age_of_donor
81Y

External IDs

Cellosaurus
CVCL_A455
Experimental Factor
BRENDA Tissue
Wiki
TSU-1621MT
ATCC
TSU-1621MT
Synonyms
TSU-1621-MT; TSU1621MT
All peaks TSU-1621MT
Download BED file
Non redundant TSU-1621MT
Download BED file
CRMs TSU-1621MT
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for TSU-1621MT

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
TSU-1621MT ERG GEO Homo sapiens GSE60477 Download (45,704)
TSU-1621MT ATRA ERG GEO Homo sapiens GSE60477 Download (78,022)
TSU-1621MT FLI1 GEO Homo sapiens GSE60477 Download (28,326)
TSU-1621MT GATA2 GEO Homo sapiens GSE60477 Download (8,310)
TSU-1621MT LMO2 GEO Homo sapiens GSE60477 Download (32,044)
TSU-1621MT LYL1 GEO Homo sapiens GSE60477 Download (12,663)
TSU-1621MT RARA GEO Homo sapiens GSE60477 Download (25,471)
TSU-1621MT RUNX1 GEO Homo sapiens GSE60477 Download (86,170)
TSU-1621MT TAL1 GEO Homo sapiens GSE60477 Download (31,488)
TSU-1621MT RXR GEO Homo sapiens GSE60477 Download (40,335)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.